Close

content

Astorg Continues to Bolster its Newly Combined Global Leader in Assisted Reproductive Technology by Acquiring FUJIFILM Irvine Scientific’s Medical Media Business

Luxembourg / London / New York / Boston / Paris – Following Astorg’s recent take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s...

GELITA launches Endotoxin Controlled Excipients for bioscience applications

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch...

Key steps to bring ADCs successfully to clinical trial

The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer...

Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3...

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January 22–23) selects six start-ups from its 26 strong field of innovators to receive the Pharmapack...

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC...

Zerion Pharma and Aché collaborate to exploit the Dispersome® technology for the improvement of two marketed drug products

Zerion Pharma< A/S (“ZERION”) today announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian pharmaceutical company. The partnership is aimed at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read